Intelligent Adaptive Subcutaneous Medical Implant System
Legal Citation
Summary of the Inventive Concept
An advanced subcutaneous medical implant system that dynamically adjusts drug delivery rates in response to a patient's changing physiological conditions, ensuring personalized and optimal treatment outcomes.
Background and Problem Solved
The original medical implant patent addressed the issue of initial drug 'burst' in existing drug implants. However, the new inventive concept tackles the limitation of static drug delivery rates in current implants, which may not be effective for patients with varying physiological conditions. This new concept provides a solution to this problem by incorporating adaptive drug release properties and machine learning algorithms to optimize treatment.
Detailed Description of the Inventive Concept
The intelligent adaptive subcutaneous medical implant system comprises a matrix with adaptive drug release properties, which can adjust drug delivery rates in response to changes in a patient's physiological conditions. The system includes a wearable device that uses artificial intelligence to predict and prevent adverse drug reactions. The implant is designed to learn a patient's drug response patterns and adapt its drug release accordingly. The modular design allows for interchangeable drug cartridges, each releasing a specific drug or combination of drugs in a controlled manner. The biodegradable matrix degrades at a predetermined rate, releasing therapeutic agents in a sustained and controlled manner.
Novelty and Inventive Step
The new claims introduce a paradigm shift in subcutaneous medical implants by incorporating adaptive drug release properties, machine learning algorithms, and wearable devices. These advancements provide a significant improvement over the original patent, enabling personalized and optimal treatment outcomes.
Alternative Embodiments and Variations
Alternative embodiments of the intelligent adaptive subcutaneous medical implant system could include variations in the matrix composition, wearable device design, and artificial intelligence algorithms. For example, the matrix could be designed to respond to specific biomarkers or the wearable device could be integrated with other health monitoring systems.
Potential Commercial Applications and Market
The intelligent adaptive subcutaneous medical implant system has significant commercial potential in the pharmaceutical and medical device industries, particularly in the areas of personalized medicine and precision healthcare. The system's ability to adapt to individual patients' needs could lead to improved treatment outcomes, reduced healthcare costs, and increased patient satisfaction.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K9/0024 |
| A | A61 | A61K31/4468 |
| A | A61 | A61K31/485 |
| A | A61 | A61K45/06 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical device engineering, specifically subcutaneous drug delivery implant systems, requiring expertise in biomaterials, pharmaceutical formulation, controlled drug release mechanisms, and biomedical device design
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or pharmaceutical scientist with advanced degree, experience in drug delivery systems, knowledge of materials science, understanding of controlled release technologies, and familiarity with implantable medical device design principles
Obviousness Rationale
A PHOSITA would recognize that the PTD's adaptive drug delivery system represents a predictable extension of the source patent's non-homogenous drug matrix concept. The fundamental innovation of controlling drug release through matrix composition is preserved, with the PTD introducing machine learning and responsive technologies as natural technological progressions. These variations represent incremental improvements using known techniques in drug delivery and biomedical engineering.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,671 |
|---|---|
| Title | Medical implant |